Healthcare & Life Sciences
Engimmune Therapeutics
Switzerlandengimmune.com
Engimmune Therapeutics is a seed startup based in Switzerland. 1 investor tracked.
Activeseed
seed
Stage
3
Investors
About Engimmune Therapeutics
Engimmune Therapeutics is a startup based in Switzerland. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Engimmune Therapeutics develops T-cell receptor (TCR)-based immunotherapies, using AI-guided protein engineering to create soluble TCR drugs targeting intracellular antigens in solid tumors and immune-mediated diseases.
Explore Engimmune Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.